SCHEMBL2353642

SCHEMBL2353642

ClNc1nc2ccccc2s1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.66
NPC1 O15118 13/20 0.61
RAB9A P51151 13/20 0.61
SMN1; SMN2 Q16637 10/20 0.61
MAPT P10636 9/20 0.61
KMT2A Q03164 9/20 0.61
MEN1 O00255 8/20 0.61
CASP3 P42574 2/20 0.61
SENP8 Q96LD8 2/20 0.61
SENP7 Q9BQF6 2/20 0.61
SENP6 Q9GZR1 2/20 0.61
ADORA1 P30542 1/20 0.61
DYRK1A Q13627 1/20 0.61
GAA P10253 4/20 0.57
CYP1A2 P05177 2/20 0.57
ALDH1A1 P00352 4/20 0.56
NFKB1 P19838 4/20 0.51
NFKB2 Q00653 4/20 0.51
RELA Q04206 4/20 0.51
LMNA P02545 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3112891 0.83 NPC1 (0.78) IDO1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL30073965 0.83 NPC1 (0.78) IDO1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL11592408 0.79 IDO1 (0.66) IDO1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL17833027 0.79 IDO1 (0.66) IDO1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL29909885 0.79 IDO1 (0.66) IDO1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL758888 0.79 IDO1 (0.66) IDO1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL9754418 0.79 IDO1 (0.66) IDO1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL11592410 0.79 IDO1 (0.66) IDO1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL1132595 0.79 IDO1 (1.00) IDO1NPC1RAB9ASMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL3130678 0.78 IDO1 (0.63) IDO1NPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103130745-B Diaryl piperazine compounds and its medical usage 中国人民解放军军事医学科学院毒物药物研究所 2017-03-15 CN disclosed
EP-2536285-A1 SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF High Point Pharmaceuticals, LLC (US) 2012-12-26 EP disclosed
WO-2011103018-A1 SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF HIGH POINT PHARMACEUTICALS, LLC (US) 2011-08-25 WO disclosed